Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|March 19, 2020
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?Grazia Rutigliano, Lavinia Bandini, Simona Sestito, et al.
The Journal of Endocrinology|March 15, 2014
Uptake and metabolic effects of 3-iodothyronamine in hepatocytesSandra Ghelardoni, Grazia Chiellini, Sabina Frascarelli, et al.
Frontiers in Pharmacology|August 21, 2018
New Multitarget Approaches in the War Against Glioblastoma: A Mini-PerspectiveSimona Sestito, Massimiliano Runfola, Marco Tonelli, et al.
Frontiers in Medicine|August 1, 2020
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative DisordersFederica Saponaro, Simona Sestito, Massimiliano Runfola, et al.
Thyroid : Official Journal of the American Thyroid Association|September 2, 2017
Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and PitfallsLeonardo Lorenzini, Sandra Ghelardoni, Alessandro Saba, et al.
International Journal of Molecular Sciences|March 28, 2024
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive DisordersCaterina Ricardi, Serena Barachini, Giorgio Consoli, et al.
Journal of Cardiovascular Pharmacology|September 10, 2009
Effects of zofenopril on cardiac sarcoplasmic reticulum calcium handlingSabina Frascarelli, Vittoria Carnicelli, Sandra Ghelardoni, et al.
Pageof 8